Leading MTP organisations sign MoU to benefit sector
26 Oct 2016
Wednesday, 26 October 2016, Melbourne, Australia—MTPConnect and AusBiotech have signed a memorandum of understanding (MoU) to work together in undertaking activities to accelerate the growth of the medical technology, biotechnology and pharmaceutical (MTP) sector in Australia.
The agreement between AusBiotech, Australia’s biotechnology industry organisation advocating for over 3,000 members, and MTPConnect, an independent, not-for-profit organisation working to boost the MTP sector in Australia, will foster greater collaboration between the two organisations to deliver their missions of engaging with, strengthening and establishing the sector nationally and as an Asia-Pacific hub.
The MoU was announced today at the AusBiotech 2016 national conference in Melbourne as part of International BioFest 2016, bringing together national and international organisations for the largest-ever gathering of the biotech ecosystem in Australia.
Sue MacLeman, CEO of MTPConnect, said that the agreement will be an important milestone for the sector.
“AusBiotech do incredible work for the biotech and medtech sector in Australia, with over 30 years of experience and a loyal membership base, and we are delighted to have signed an MoU to ensure that our two organisations will work closely for the benefit of the sector.
“Together, MTPConnect and AusBiotech will be able to have significant impact on boosting innovation, sustainability and growth of medtech and biotech in Australia, achieving greater commercialisation and competitiveness in the global market through joint advocacy, training, and fostering international connections.”
Glenn Cross, CEO of AusBiotech, said:
“AusBiotech have supported MTPConnect since its formation in 2015, and we look forward to working in partnership with the industry growth centre in the future. This MoU will drive our already aligned goals to devise tactics that will deliver real-world, positive outcomes to the Australian medical technology and pharmaceutical sector.”
- ENDS -
About MTPConnect
MTPConnect was formed as a not-for-profit organisation in November 2015 as part of the federal government’s $250 million Industry Growth Centres Initiative to accelerate the rate of growth of the MTP sector to achieve greater commercialisation and establish Australia as an Asia-Pacific hub for MTP companies.
The MTPConnect Head Office is located at the New Horizons Building at Monash University, co-located with CSIRO and industry. There are also key hubs at the University of Sydney’s Institute of Biomedical Engineering and Technology and the Medical Device Research Institute at Flinders University at Tonsley in Adelaide.
About AusBiotech
AusBiotech is Australia’s biotechnology organisation, working on behalf of members for 30 years to provide representation and services to promote the global growth of Australian biotechnology. AusBiotech is a well-connected network of over 3,000 members in the life sciences, including therapeutics, medical technology (devices and diagnostics), food technology and agricultural, environmental and industrial sectors.
Media inquiries
Zoe Stephenson
Corporate Communications Manager, MTPConnect
+61 3 9905 1757
zoe.stephenson@mtpconnect.org.au
Lorraine Chiroiu
Deputy Chief Executive Officer, AusBiotech
0429 801 118
lchiroiu@ausbiotech.org